Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 4:32 PM View:  | Entrada Therapeutics, Inc. (TRDA) | 26-Sep-24 | Private Sale (Planned) | 847 | $16.00 | $13,552.00 | (< 1%) 126.0K to 125.15K | |
| 10-Sep-24 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 09-Sep-24 | Sale (Planned) | 1,904 | $15.07 | $28,690.20 | (1%) 127.9K to 126.0K | |
| 10-Sep-24 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 06-Sep-24 | Private Sale (Planned) | 399 | $15.19 | $6,062.69 | (< 1%) 128.3K to 127.9K | |
| 05-Sep-24 6:48 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Sep-24 | Payment of Exercise | 171 | $15.13 | $2,586.55 | (< 1%) 128.47K to 128.3K | |
| 05-Sep-24 6:48 PM View: | Entrada Therapeutics, Inc. (TRDA) | 04-Sep-24 | Payment of Exercise | 983 | $15.42 | $15,161.20 | (< 1%) 129.45K to 128.47K | |
| 05-Sep-24 6:48 PM View: | Entrada Therapeutics, Inc. (TRDA) | 03-Sep-24 | Payment of Exercise | 654 | $16.08 | $10,518.50 | (< 1%) 130.11K to 129.45K | |
| 20-Aug-24 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 16-Aug-24 | Option Exercise | 20,000 | $1.74 | $34,800.00 | 15% 137.2K to 157.2K | |
| 20-Aug-24 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 16-Aug-24 | Planned Option Sale | 20,000 | $16.27 | $325,350.00 | (13%) 157.2K to 137.2K | |
| 20-Aug-24 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 16-Aug-24 | Sale (Planned) | 7,097 | $16.27 | $115,451.00 | (5%) 137.2K to 130.11K | |
| 08-Mar-24 4:34 PM View: | Entrada Therapeutics, Inc. (TRDA) | 06-Mar-24 | Private Sale (Planned) | 1,826 | $12.32 | $22,498.70 | (1%) 139.03K to 137.2K | |
| 05-Mar-24 7:46 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Mar-24 | Payment of Exercise | 1,486 | $12.28 | $18,246.30 | (1%) 140.52K to 139.03K | |
| 05-Mar-24 7:46 PM View: | Entrada Therapeutics, Inc. (TRDA) | 04-Mar-24 | Payment of Exercise | 752 | $12.94 | $9,728.32 | (< 1%) 141.27K to 140.52K | |
| 05-Mar-24 7:46 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-24 | Grant | 93,100 | -- | -- | 193% 48.17K to 141.27K | |
| 06-Sep-23 5:07 PM View: | Entrada Therapeutics, Inc. (TRDA) | 06-Sep-23 | Sale (Planned) | 972 | $13.47 | $13,089.10 | (2%) 49.14K to 48.17K | |
| 06-Sep-23 5:07 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Sep-23 | Payment of Exercise | 436 | $14.46 | $6,305.65 | (< 1%) 49.58K to 49.14K | |
| 06-Sep-23 5:07 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Sep-23 | Grant | 14,200 | -- | -- | 40% 35.38K to 49.58K | |
| 12-Jul-23 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 11-Jul-23 | Sale (Planned) | 3,897 | $18.05 | $70,333.10 | (10%) 39.27K to 35.38K | |
| 12-Jul-23 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 10-Jul-23 | Private Sale (Planned) | 3,200 | $18.00 | $57,605.10 | (8%) 42.47K to 39.27K | |
| 22-Jun-23 4:46 PM View: | Entrada Therapeutics, Inc. (TRDA) | 22-Jun-23 | Sale (Planned) | 7,097 | $16.02 | $113,700.00 | (14%) 49.57K to 42.47K | |
| 22-Jun-23 4:46 PM View: | Entrada Therapeutics, Inc. (TRDA) | 20-Jun-23 | Private Sale (Planned) | 8,885 | $14.94 | $132,704.00 | (15%) 58.45K to 49.57K | |
| 03-Mar-23 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 02-Mar-23 | Payment of Exercise | 1,028 | $11.60 | $11,920.90 | (1%) 73.68K to 72.66K | |
| 03-Mar-23 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-23 | Grant | 28,400 | -- | -- | 63% 45.28K to 73.68K | |
| 02-Nov-22 4:54 PM View: | Entrada Therapeutics, Inc. (TRDA) | 31-Oct-22 | Private Sale (Planned) | 2,100 | $24.05 | $50,495.10 | (4%) 47.38K to 45.28K | |
| 27-Oct-22 6:48 PM View: | Entrada Therapeutics, Inc. (TRDA) | 25-Oct-22 | Private Sale (Planned) | 9,348 | $20.77 | $194,191.00 | (16%) 56.73K to 47.38K | |
| 24-Oct-22 5:13 PM View: | Entrada Therapeutics, Inc. (TRDA) | 24-Oct-22 | Sale (Planned) | 2,404 | $19.30 | $46,401.90 | (4%) 59.13K to 56.73K | |
| 24-Oct-22 5:13 PM View: | Entrada Therapeutics, Inc. (TRDA) | 21-Oct-22 | Sale (Planned) | 2,771 | $18.28 | $50,667.70 | (4%) 61.91K to 59.13K | |
| 24-Oct-22 5:13 PM View: | Entrada Therapeutics, Inc. (TRDA) | 20-Oct-22 | Private Sale (Planned) | 905 | $18.07 | $16,356.50 | (1%) 62.81K to 61.91K | |
| 28-Sep-22 5:08 PM View: | Entrada Therapeutics, Inc. (TRDA) | 26-Sep-22 | Private Sale (Planned) | 1,544 | $15.45 | $23,853.50 | (2%) 64.36K to 62.81K | |
| 23-Sep-22 4:55 PM View: | Entrada Therapeutics, Inc. (TRDA) | 23-Sep-22 | Sale (Planned) | 1,018 | $15.07 | $15,340.60 | (2%) 65.37K to 64.36K | |
| 23-Sep-22 4:55 PM View: | Entrada Therapeutics, Inc. (TRDA) | 21-Sep-22 | Private Sale (Planned) | 3,275 | $15.13 | $49,537.00 | (5%) 68.65K to 65.37K | |
| 19-Sep-22 4:34 PM View: | Entrada Therapeutics, Inc. (TRDA) | 15-Sep-22 | Private Sale (Planned) | 100 | $15.01 | $1,501.00 | (< 1%) 68.75K to 68.65K | |
| 12-Sep-22 4:14 PM View: | Entrada Therapeutics, Inc. (TRDA) | 09-Sep-22 | Sale (Planned) | 865 | $15.06 | $13,030.90 | (1%) 69.61K to 68.75K | |
| 12-Sep-22 4:14 PM View: | Entrada Therapeutics, Inc. (TRDA) | 08-Sep-22 | Private Sale (Planned) | 912 | $15.15 | $13,814.20 | (1%) 70.53K to 69.61K | |
| 06-Sep-22 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Sep-22 | Grant | 5,632 | -- | -- | 9% 64.89K to 70.53K | |
| 29-Jun-22 4:02 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Jun-22 | Private Sale (Planned) | 7,714 | $13.00 | $100,282.00 | (11%) 72.61K to 64.89K | |
| 03-Mar-22 4:11 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-22 | Grant | 11,263 | -- | -- | 18% 61.34K to 72.61K |